Remove 2017 Remove DEA Remove Epilepsy
article thumbnail

Constitutionality of Cannabis: Federal Lawsuit Against DEA, DOJ Proceeds

Marijuana Lawyer Blog

As our Los Angeles marijuana patient attorneys can explain, the crux of the argument by plaintiffs of the claim, first filed in 2017, is that the designation ignores the merits of the drug for medicinal purposes. Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government.

DEA 40
article thumbnail

Nevada veterinarians can now treat patients with certain cannabis products

Cannabis Law Report

1, 2017, following a 2016 ballot measure. For several millennia, humans have used cannabinoids for pain, epilepsy, gastrointestinal disorders, and even infections. Nevada voters approved medical marijuana for people by ballot initiative in 2000. Cannabis became legal for recreational use in the state on Jan.

Patients 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Guest Post: Is CBD Legal? Federal & State Laws [2019]

Cannabis Law Report

Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. In 2017, Kentucky approved the House Bill 333 that legalized the consumption and retail sale of CBD containing up to 0.3% In 2014, Mississippi legalized CBD for epileptic patients.

article thumbnail

The Variety of Health Conditions That Medical Marijuana can Treat

The Joint Blog

Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.

article thumbnail

Industry Trembles After FDA Cracks The Whip

Cannabis Law Report

Seq (1970) and Drug Enforcement Administration’s (“DEA”) clutches, 2019 hemp production and sales exploded. up 116% over Q3 2017); and $13.6 A wildly popular nutritional supplement and food additive, oil based hemp derived products like CBD racked up $1.1 stores and up 57% from prior year); $16.8 Budgeted at $6.1

Food 10
article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

6 However, marijuana vaping did significantly increase between 2017 and 2018, mirroring trends in youth tobacco use. 7 While the lifetime use remains relatively stable for this cohort, from 2015-2017, past year and past month use increased 2.7% and 2.3%, respectively. and 2.3%, respectively.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. IMAJ, FEBRUARY 2017.